Susquehanna International Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.34M | Sell |
|
|||||
|
2025
Q2 | $2.88M | Buy |
|
|||||
|
2025
Q1 | $1.32M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $217K | Sell |
|
|||||
|
2024
Q2 | $254K | Sell |
|
|||||
|
2024
Q1 | $3.23M | Sell |
|
|||||
|
2023
Q4 | $2.68M | Buy |
|
|||||
|
2023
Q3 | $856K | Buy |
|
|||||
|
2023
Q2 | $297K | Sell |
|
|||||
|
2023
Q1 | $208K | Sell |
|
|||||
|
2022
Q4 | $304K | Buy |
|
|||||
|
2022
Q3 | $146K | Sell |
|
|||||
|
2022
Q2 | $187K | Buy |
|
|||||
|
2022
Q1 | $348K | Sell |
|
|||||
|
2021
Q4 | $1.93M | Buy |
|
|||||
|
2021
Q3 | $2.27M | Sell |
|
|||||
|
2021
Q2 | $3.58M | Sell |
|
|||||
|
2021
Q1 | $4.01M | Buy |
|
|||||
|
2020
Q4 | $1.63M | Sell |
|
|||||
|
2020
Q3 | $1.77M | Buy |
|
|||||
|
2020
Q2 | $615K | Sell |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $1.25M | Buy |
|
|||||
|
2019
Q3 | $594K | Sell |
|
|||||
|
2019
Q2 | $909K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.23M | Buy |
|
|||||
|
2018
Q3 | $126K | Sell |
|
|||||
|
2018
Q2 | $736K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.04M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $570K | Buy |
|
|||||
|
2016
Q3 | $92K | Sell |
|
|||||
|
2016
Q2 | $306K | Buy |
|
|||||
|
2016
Q1 | $272K | Sell |
|
|||||
|
2015
Q4 | $607K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $130K | Sell |
|
|||||
|
2014
Q4 | $159K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $411K | Buy |
|